Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
14.41
-0.33 (-2.24%)
Jun 10, 2026, 3:00 PM CST
SHA:600521 Stock Forecast
Stock Price Forecast
The 3 analysts that cover SHA:600521 stock have a consensus rating of "Hold" and an average price target of ¥17.70, which forecasts a 22.83% increase in the stock price over the next year. The lowest target is ¥12.00 and the highest is ¥21.50.
Price Target: ¥17.70 (+22.83%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for SHA:600521 stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
9.41B
from 8.59B
Increased by 9.58%
Revenue Next Year
10.28B
from 9.41B
Increased by 9.25%
EPS This Year
0.94
from 0.11
Increased by 754.55%
EPS Next Year
0.33
from 0.94
Decreased by -64.89%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.6B | ||
| Avg | 9.4B | ||
| Low | 9.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.0% | ||
| Avg | 9.6% | ||
| Low | 7.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.94 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 754.5% | ||
| Low | - |